JP Morgan Chase’s CST Brands, Inc. CST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-808,033
Closed -$38.9M 5445
2017
Q1
$38.9M Sell
808,033
-28,559
-3% -$1.38M 0.01% 1064
2016
Q4
$40.3M Buy
836,592
+395,653
+90% +$19M 0.01% 1025
2016
Q3
$21.2M Buy
440,939
+330,114
+298% +$15.2M 0.01% 1331
2016
Q2
$4.78M Buy
110,825
+20,346
+22% +$806K ﹤0.01% 2322
2016
Q1
$3.46M Sell
90,479
-3,159
-3% -$116K ﹤0.01% 2413
2015
Q4
$3.67M Buy
93,638
+56,539
+152% +$2.07M ﹤0.01% 2412
2015
Q3
$1.25M Sell
37,099
-57,587
-61% -$2.09M ﹤0.01% 2997
2015
Q2
$3.7M Sell
94,686
-231,550
-71% -$9.64M ﹤0.01% 2574
2015
Q1
$14.3M Sell
326,236
-118,879
-27% -$5.16M ﹤0.01% 1662
2014
Q4
$19.4M Buy
445,115
+204,536
+85% +$8.21M ﹤0.01% 1490
2014
Q3
$8.65M Sell
240,579
-160,969
-40% -$5.57M ﹤0.01% 2024
2014
Q2
$13.9M Buy
401,548
+46,085
+13% +$1.5M ﹤0.01% 1561
2014
Q1
$11.1M Buy
355,463
+175,699
+98% +$5.58M ﹤0.01% 1666
2013
Q4
$6.6M Buy
179,764
+42,502
+31% +$1.39M ﹤0.01% 1999
2013
Q3
$4.09M Sell
137,262
-603,786
-81% -$18.9M ﹤0.01% 2317
2013
Q2
$22.8M Buy
+741,048
New +$23.6M 0.01% 1175

Other funds holding CST

JP Morgan Chase's CST Position: Q2 2017 in Review

JP Morgan Chase sold out of CST Brands, Inc. (CST) in Q2 2017, closing a stake of 808,033 shares — an estimated $38.9M sold.

JP Morgan Chase first reported a position in CST in Q2 2013 and held it in 16 quarters. The position peaked at $40.3M in Q4 2016. 2 funds tracked by Wall St. Rank hold CST as of Q2 2017.

  • JP Morgan Chase reported no remaining CST Brands, Inc. position as of Q2 2017 after selling out during the quarter.
  • JP Morgan Chase sold 808,033 CST Brands, Inc. shares in Q2 2017, an estimated $38.9M.
  • JP Morgan Chase first reported a position in CST Brands, Inc. in Q2 2013 and held it in 16 quarters.
  • JP Morgan Chase's CST Brands, Inc. position peaked at $40.3M in Q4 2016.
  • 2 funds tracked by Wall St. Rank held CST Brands, Inc. as of Q2 2017.

Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.